Tue, December 17, 2024
Mon, December 16, 2024
Sun, December 15, 2024

Jeremy Grantham's GMO Goes Mainstream With ETF and Mega-Cap Bets

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -goes-mainstream-with-etf-and-mega-cap-bets.html
  Print publication without navigation Published in Stocks and Investing on by MSN
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
Jeremy Grantham's valuation-oriented investment firm is famous on Wall Street for trumpeting the contrarian, and decidedly bearish, views of its co-founder, seemingly every passing year.
Jeremy Grantham's investment firm, GMO, has launched its first exchange-traded fund (ETF), the GMO U.S. Quality ETF (QLTY), marking its entry into the mainstream investment market. This move comes as part of a broader strategy to make GMO's investment strategies more accessible to retail investors. The ETF focuses on high-quality U.S. companies, emphasizing those with strong balance sheets, stable earnings, and low debt, which aligns with Grantham's long-term value investing philosophy. Additionally, GMO has been betting on mega-cap tech stocks, recognizing their resilience and market dominance despite previous skepticism about their valuations. This strategic shift reflects GMO's adaptation to current market trends while maintaining its core investment principles.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/other/jeremy-grantham-s-gmo-goes-mainstream-with-etf-and-mega-cap-bets/ar-AA1vXjW8 ]